Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
Clinical trial NCT03485911 · COMPLETED
Trial details
- NCT number
- NCT03485911
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2019-04-10
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.